Causal Therapy of COVID-19: Critical Review and Prospects
The COVID-19 outbreak started in December 2019 in China has spread over all countries of the world within few month acquiring a pandemic nature, the incident population counting millions. The pathogenic mechanisms of the new coronaviral infection caused by never-before-seen virus SARS-CoV2 are yet t...
Saved in:
Main Authors: | N. V. Beloborodova, E. V. Zuev, M. N. Zamyatin, V. G. Gusarov |
---|---|
Format: | Article |
Language: | English |
Published: |
Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia
2020-12-01
|
Series: | Общая реаниматология |
Subjects: | |
Online Access: | https://www.reanimatology.com/rmt/article/view/1987 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 Therapy: the Role of Antirheumatic Drugs
by: M. A. Litvinova, et al.
Published: (2021-10-01) -
Janus kinase inhibitors in the treatment of psoriatic arthritis
by: E. Yu. Loginova, et al.
Published: (2022-02-01) -
BARICITINIB: NEW PHARMACOTHERAPY OPTIONS FOR RHEUMATOID ARTHRITIS AND OTHER IMMUNE-MEDIATED INFLAMMATORY RHEUMATIC DISEASES
by: E. L. Nasonov, et al.
Published: (2020-06-01) -
Recommendations for the treatment of axial spondyloarthritis: An analysis of the updated ASAS/EULAR 2022 clinical guidelines
by: Sh. F. Erdes, et al.
Published: (2025-05-01) -
Baricitinib: key results of long-term use in rheumatoid arthritis
by: N. V. Chichasova, et al.
Published: (2024-08-01)